Hepatitis E Vaccine Data Support Pregnancy Use
New clinical data released this week indicates that the Hecolin vaccine, a recombinant hepatitis E vaccine, demonstrates a favorable safety and efficacy profile for use during pregnancy. This development, highlighted in recent medical reports, offers a potential breakthrough in preventing maternal and neonatal mortality associated with the Hepatitis E virus (HEV), which disproportionately impacts pregnant…